Abstract

The apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3 (APOBEC3) proteins are cell-encoded cytidine deaminases, some of which, such as APOBEC3G (A3G) and APOBEC3F (A3F), act as potent human immunodeficiency virus type-1 (HIV-1) restriction factors. These proteins require packaging into HIV-1 particles to exert their antiviral activities, but the molecular mechanism by which this occurs is incompletely understood. The nucleocapsid (NC) region of HIV-1 Gag is required for efficient incorporation of A3G and A3F, and the interaction between A3G and NC has previously been shown to be RNA-dependent. Here, we address this issue in detail by first determining which RNAs are able to bind to A3G and A3F in HV-1 infected cells, as well as in cell-free virions, using the unbiased individual-nucleotide resolution UV cross-linking and immunoprecipitation (iCLIP) method. We show that A3G and A3F bind many different types of RNA, including HIV-1 RNA, cellular mRNAs and small non-coding RNAs such as the Y or 7SL RNAs. Interestingly, A3G/F incorporation is unaffected when the levels of packaged HIV-1 genomic RNA (gRNA) and 7SL RNA are reduced, implying that these RNAs are not essential for efficient A3G/F packaging. Confirming earlier work, HIV-1 particles formed with Gag lacking the NC domain (Gag ΔNC) fail to encapsidate A3G/F. Here, we exploit this system by demonstrating that the addition of an assortment of heterologous RNA-binding proteins and domains to Gag ΔNC efficiently restored A3G/F packaging, indicating that A3G and A3F have the ability to engage multiple RNAs to ensure viral encapsidation. We propose that the rather indiscriminate RNA binding characteristics of A3G and A3F promote functionality by enabling recruitment into a wide range of retroviral particles whose packaged RNA genomes comprise divergent sequences.

Highlights

  • Consistent with the RNA binding profiles, many RNAs can promote packaging provided that those RNAs are, themselves, packaged. These observations suggest that apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3 (APOBEC3) packaging lacks selectivity and is driven by the non-specific RNA binding capabilities of these proteins. We speculate that this model accounts for the broad range of retro-elements that are susceptible to repression by individual APOBEC3 proteins, and that such substrates cannot escape APOBEC3-mediated inhibition through sequence variation

  • The apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3 (APOBEC3, or A3) proteins have been identified as potent antiviral effector proteins [1,2]

  • The encapsidation of APOBEC3 proteins into viral particles is essential for their antiviral activity, and a complete description of APOBEC3 protein function will require a full understanding of the packaging mechanism

Read more

Summary

Introduction

The apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3 (APOBEC3, or A3) proteins have been identified as potent antiviral effector proteins [1,2]. There are seven family members in humans, each of which contains one (A3A, A3C and A3H) or two (A3B, A3D, A3F and A3G) characteristic zinc-coordination domains, one of which is catalytically active [3]. These proteins have been identified as inhibitors of retroviruses such as human immunodeficiency virus type-1 (HIV-1) [4], simian immunodeficiency viruses, murine leukaemia virus [5,6,7] and mouse mammary tumour virus [8], as well as viruses from other families such as hepatitis B virus [9], adeno-associated virus [10] and endogenous retroelements [11]. The encapsidation of APOBEC3 proteins into viral particles is essential for their antiviral activity, and a complete description of APOBEC3 protein function will require a full understanding of the packaging mechanism

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call